Pure Biologics S.A. (WSE: PUR)
Poland
· Delayed Price · Currency is PLN 20.20
-0.60 (-2.88%)
Sep 27, 2024, 5:04 PM CET
Pure Biologics Revenue
Pure Biologics had revenue of 3.00K PLN in the quarter ending March 31, 2024, a decrease of -89.66%. This brings the company's revenue in the last twelve months to 69.00K, down -88.04% year-over-year. In the year 2023, Pure Biologics had annual revenue of 95.00K, down -85.65%.
Revenue (ttm)
69.00K
Revenue Growth
-88.04%
P/S Ratio
n/a
Revenue / Employee
2.38K
Employees
51
Market Cap
74.59M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Krka, d. d. | 8.06B |
| NEUCA S.A. | 12.13B |
| Sopharma AD | 4.35B |
| Synektik Spólka Akcyjna | 618.67M |
| Celon Pharma S.A. | 206.81M |
| Ryvu Therapeutics S.A. | 82.39M |
| Voxel S.A. | 476.19M |
| Selvita S.A. | 329.02M |